Every Issue
The Conversation
In mailboxes, pharmacies, medical offices and elsewhere, the annual HIV Drug Guide and the 2023 HIV Drug Chart could be found, and readers shared their enthusiasm.
Note from the Acting Editor in Chief
In Friendship
Briefly | May + June 2023
Doxy-PEP cuts STI cases
The Category Is: Support network
If you’re living with HIV, do you have a support network—friends or loved ones—you can turn to when you need care?
Positive Aging: Meds and labs: By the numbers
How understanding your lab test results can help you stay healthy
POZ Advocate: Tipping the scales on PrEP
How a conservative Texas judge’s ruling threatens HIV prevention nationwide
Being Bridgette: Authenticity
Showing up as who you truly are takes effort, but it’s worth it
This Issue
I’m still standing
Reflections on surviving several bouts of cancer, while living with HIV
Unreliable sources
Amid COVID-19, misinformation and disinformation target HIV
Another survey with HIV long-term survivors
Another survey with HIV long-term survivors: Have we learned anything new?
CROI 2023
CROI 2023: Diversity in studies and community input in cure research today
Highlights from the 2023 Pre-CROI Community HIV Cure Workshop
CROI 2023: Sex talk at CROI
Beating off STIs with DOXYVAC, doxy-PEP, Apretude, vaginal ring, implant and booty butter
Partners in Research: Part II
Active involvement
People living with HIV share their experiences as cure research participants
Actively involvement: Clark Hawley
Feeling good about being part of the scientific process
Actively involvement: Anonymous
An HIV-negative partner’s perspective
Actively involvement: Richard Strange
Serial ATI participation
Actively involvement: Thomas J. Villa
ATI: ‘A trial interruptus’